News

Deal Announcements

Aldea Pharma Closes Series B Venture Capital

Tuesday, August 26, 2014 5:30:00 AM PDT | VentureDeal
   Redwood City, California  --  Aldea Pharmaceuticals has secured $24 million in new venture capital financing, according to a company statement.

Aldea is developing treatments for individuals with acute alcohol intoxication and for sufferers of Fanconi anemia disease.

Investors included RusnanonMedInvest, WuXi PharmaTech, Canaan Partners and Correlation Ventures.

The company will use the funds to advance its lead candidates through continued development and trials.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1